Stock comparison
JOHNSON & JOHNSON is 93.0x more valuable than Xenon Pharmaceuticals Inc. by market capitalization ($622.64 B vs $6.70 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
JNJ is larger
JOHNSON & JOHNSON is 93.0x more valuable than Xenon Pharmaceuticals Inc. by market capitalization ($622.64 B vs $6.70 B).
Market value leader
JNJ
JOHNSON & JOHNSON is 93.0x more valuable than Xenon Pharmaceuticals Inc. by market capitalization ($622.64 B vs $6.70 B).
Revenue leader
JNJ
XENE: $7.50M vs JNJ: $94.19B.
Profit leader
JNJ
XENE: -$345.91M vs JNJ: $26.80B.
Margin leader
JNJ
XENE: -4612.1% vs JNJ: 28.5% net margin.
| Metric | XENE | JNJ |
|---|---|---|
| Market cap | $6.70 B | $622.64 B |
| US-listed rank | #1201 | #18 |
| Revenue (latest FY) | $7.50M | $94.19B |
| Net income (latest FY) | -$345.91M | $26.80B |
| Net margin | -4612.1% | 28.5% |
| P/E (trailing FY) | - | 23.2x |
| SEC filings | 761 | 990 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
JOHNSON & JOHNSON is 93.0x more valuable than Xenon Pharmaceuticals Inc. by market capitalization ($622.64 B vs $6.70 B).
In their latest fiscal years, Xenon Pharmaceuticals Inc. reported $7.50M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: Xenon Pharmaceuticals Inc. and JOHNSON & JOHNSON, or browse the full rankings.